My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

234.00 +1.64 (+0.71%)

Official Closing Price Updated: 7:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

89 90 Next >

Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income ↗

June 24, 2024

Buying dividend stocks for income is a smart investment strategy to juice your portfolio's returns even in down markets.

Via InvestorPlace

AbbVie Inc. Dividend Stock Analysis - Saturday, June 22 ↗

June 22, 2024

Here are some highlights from a detailed, quantitative analysis AbbVie Inc. stock. Let's take a closer look at various factors, such as the stock's value and dividend.

Via Talk Markets

Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal ↗

June 22, 2024

FutureGen Biopharm out-licensed global rights for its next-gen TL1A antibody to AbbVie in a $1.7 billion agreement. Also, MabCare Therapeutics out-licensed global rights for its ADC targeting...

Via Talk Markets

Check Out What Whales Are Doing With ABBV ↗

June 21, 2024

Via Benzinga

3 Biotech Stocks to Buy Now: June 2024 ↗

June 21, 2024

These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,

Via InvestorPlace

AbbVie Stock Price Forecast: $200 On The Cards? ↗

June 20, 2024

Strategic partnerships and acquisitions enhance AbbVie's pipeline.

Via Talk Markets

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years ↗

June 20, 2024

Via Benzinga

Earn Income While Playing The Hottest Sectors ↗

June 19, 2024

Via Talk Markets

Looking Into AbbVie's Recent Short Interest ↗

June 13, 2024

Via Benzinga

Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for June 2024 ↗

June 20, 2024

Discover top retirement stocks with strong buy ratings, offering reliable growth and income to ensure a comfortable retirement.

Via InvestorPlace

Topics Retirement

10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year ↗

June 20, 2024

The power of compounding can build huge amounts of passive income.

Via The Motley Fool

7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027 ↗

June 20, 2024

Discover these blue-chip stocks to buy in the biotechnology, banking, pharmaceuticals, tobacco, restaurants, and entertainment industries.

Via InvestorPlace

3 High-Dividend Stocks to Buy and Hold Forever: June 2024 Edition ↗

June 20, 2024

Looking for high-yield dividend stocks to buy and hold? Take a look at these three buy-rated Dividend Aristocrats.

Via InvestorPlace

2 Super Smart Dividend Stocks to Buy With $10,000 Right Now ↗

June 19, 2024

Don't sleep on the value of quality dividends.

Via The Motley Fool

Comparative Study: AbbVie And Industry Competitors In Biotechnology Industry ↗

June 11, 2024

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,100 Today ↗

June 10, 2024

Via Benzinga

Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

June 18, 2024

Via Benzinga

Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' ↗

June 17, 2024

On CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals, Kevin Simpson named ConocoPhillips, and Rob Sechan suggested AbbVie, with all four stocks having...

Via Benzinga

2 Dividend Stocks That Could Pay You for Life ↗

June 16, 2024

There are other reasons to love these businesses, too.

Via The Motley Fool

7 A-Rated Biotech Stocks Worth Betting on in June ↗

June 14, 2024

A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation.

Via InvestorPlace

The Dividend Defenders: 3 Stocks That Will Protect and Grow Your Wealth Dividend Stocks ↗

June 14, 2024

Are you looking for some defenders for your portfolio? Here are three dividend stocks to protect and grow your wealth.

Via InvestorPlace

Blue-Chip Bonanzas: 3 Industry Leaders Trading at Unbelievable Discounts ↗

June 12, 2024

Thanks to the predictability of big businesses, the bargains found among undervalued blue-chip stocks are simply more trustworthy.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 11, 2024

Via Benzinga

Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside ↗

June 07, 2024

Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 07, 2024

Via Benzinga

AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability ↗

June 07, 2024

Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance...

Via Benzinga

AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades' ↗

June 07, 2024

AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners.

Via Benzinga

AbbVie's Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated Ovarian Cancer Patients ↗

June 06, 2024

AbbVie announced Phase 2 PICCOLO trial results for Elahere in heavily pre-treated ovarian cancer patients. The trial achieved a 51.9% objective response rate.

Via Benzinga

Investing in Biotech: High Risk for a Potentially High Reward

June 06, 2024

Biotech is an exciting and promising area, and investors with some patience, the stomach for volatility, and a high risk tolerance can potentially benefit.

Via MarketBeat

7 Stocks That Could Safely 10X by 2030 ↗

June 06, 2024

Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align.

Via InvestorPlace

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

89 90 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.